Phillips KA - Search Results

1

How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey.

Marshall DA, Johnson FR, Kulin NA, Ozdemir S, Walsh JM, Marshall JK, Van Bebber S, Phillips KA. Marshall DA, et al. Among authors: phillips ka. Health Econ. 2009 Dec;18(12):1420-39. doi: 10.1002/hec.1437. Health Econ. 2009. PMID: 19191268 Free PMC article.

2

Measuring what people value: a comparison of "attitude" and "preference" surveys.

Phillips KA, Johnson FR, Maddala T. Phillips KA, et al. Health Serv Res. 2002 Dec;37(6):1659-79. doi: 10.1111/1475-6773.01116. Health Serv Res. 2002. PMID: 12546291 Free PMC article.

3

Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing.

Phillips KA, Maddala T, Johnson FR. Phillips KA, et al. Health Serv Res. 2002 Dec;37(6):1681-705. doi: 10.1111/1475-6773.01115. Health Serv Res. 2002. PMID: 12546292 Free PMC article.

4

An introduction to cost-effectiveness and cost-benefit analysis of pharmacogenomics.

Phillips KA, Veenstra D, Van Bebber S, Sakowski J. Phillips KA, et al. Pharmacogenomics. 2003 May;4(3):231-9. doi: 10.1517/phgs.4.3.231.22691. Pharmacogenomics. 2003. PMID: 12718713 Review.

5

Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs.

Phillips KA, Veenstra DL, Ramsey SD, Van Bebber SL, Sakowski J. Phillips KA, et al. Am J Manag Care. 2004 Jul;10(7 Pt 1):425-32. Am J Manag Care. 2004. PMID: 15298364 Free article. Review.

6

A systematic review of cost-effectiveness analyses of pharmacogenomic interventions.

Phillips KA, Van Bebber SL. Phillips KA, et al. Pharmacogenomics. 2004 Dec;5(8):1139-49. doi: 10.1517/14622416.5.8.1139. Pharmacogenomics. 2004. PMID: 15584880 Review.

7

Measuring the value of pharmacogenomics.

Phillips KA, Van Bebber SL. Phillips KA, et al. Nat Rev Drug Discov. 2005 Jun;4(6):500-9. doi: 10.1038/nrd1749. Nat Rev Drug Discov. 2005. PMID: 15915153 Review.

8

Patient costs for medication abortion: results from a study of five clinical practices.

Van Bebber SL, Phillips KA, Weitz TA, Gould H, Stewart F. Van Bebber SL, et al. Among authors: phillips ka. Womens Health Issues. 2006 Jan-Feb;16(1):4-13. doi: 10.1016/j.whi.2005.07.006. Womens Health Issues. 2006. PMID: 16487919

9

Regulatory perspectives on pharmacogenomics: a review of the literature on key issues faced by the United States Food and Drug Administration.

Phillips KA, Van Bebber SL. Phillips KA, et al. Med Care Res Rev. 2006 Jun;63(3):301-26. doi: 10.1177/1077558706287020. Med Care Res Rev. 2006. PMID: 16651395 Review.

10

Diagnostics and biomarker development: priming the pipeline.

Phillips KA, Van Bebber S, Issa AM. Phillips KA, et al. Nat Rev Drug Discov. 2006 Jun;5(6):463-9. doi: 10.1038/nrd2033. Epub 2006 May 19. Nat Rev Drug Discov. 2006. PMID: 16718275 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

816 results

Search Page

Filters